As of May 2022 Mallinckrodt Pharmaceuticals has a market cap of $6.51 Million. This makes Mallinckrodt Pharmaceuticals the world's 6230th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $6.51 M | -38.52% |
2021 | $0.01 B | -37.72% |
2020 | $0.01 B | -94.21% |
2019 | $0.29 B | -77.7% |
2018 | $1.31 B | -32.41% |
2017 | $1.94 B | -62.65% |
2016 | $5.21 B | -37.92% |
2015 | $8.40 B | -27.02% |
2014 | $11.50 B | 279.32% |
2013 | $3.03 B |
On May 21st, 2022 the market cap of Mallinckrodt Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $465.70 B | 7,152,131.98% | ๐บ๐ธ USA |
![]() General Electric GE | $82.82 B | 1,271,909.10% | ๐บ๐ธ USA |
![]() Zogenix ZGNX | $1.50 B | 22,939.41% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $9.40 B | 144,335.48% | ๐ฎ๐ฑ Israel |